Edoxaban dose, frailty, and outcomes in patients with atrial fibrillation: the ETNA-AF-Europe 4-year follow-up

Authors: S Fumagalli, I Diemberger, J J Komen, E M Fronk, P Kirchhof, R De Caterina

Published: 2024-10-28

DOI: 10.1093/eurheartj/ehae666.3134

Source: Full article